; (B) factors that may mitigate the effects of fetal alcohol exposure; and (C) other research that the Director of the Institute determines to be appropriate with respect to conditions that develop as a result of in-utero substance exposure. (c) Surveillance, public health research, and prevention activities (1) In general The Secretary, acting through the Director of the National Center on Birth Defects and Developmental Disabilities of the Centers for Disease Control and Prevention, shall facilitate surveillance, public health research, and prevention of FASD in accordance with this subsection. (2) Surveillance, public health research, and prevention In carrying out this subsection, the Secretary shall— (A) integrate into clinical practice the evidence-based standard case definition for diagnosis of fetal alcohol syndrome and, in collaboration with the Director of the Institute, the Director of the Centers for Disease Control and Prevention, the Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders established under section 399H–1, researchers, and other experts in the field, develop standard, evidence-based clinical diagnostic guidelines, and criteria for all other fetal alcohol spectrum disorders; (B) conduct applied public health prevention research to identify evidence-based strategies for reducing alcohol-exposed pregnancies in women at high risk for alcohol-exposed pregnancies; (C) disseminate and provide the necessary training and support to implement evidence-based strategies developed under subparagraph (B) to— (i) hospitals, Federally-qualified health centers, residential and outpatient substance use treatment programs, and other appropriate health care providers; (ii) educational settings; (iii) social work and child welfare offices; (iv) foster care providers and adoption agencies; (v) State offices and other agencies providing services to individuals with disabilities; (vi) mental health treatment facilities; and (vii) other entities that the Secretary determines to be appropriate